BioSenic (Belgium) Performance

BIOS Stock   0  0.0001  4.76%   
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and BioSenic are completely uncorrelated. At this point, BioSenic SA has a negative expected return of -0.12%. Please make sure to confirm BioSenic's rate of daily change and the relationship between the market facilitation index and period momentum indicator , to decide if BioSenic SA performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days BioSenic SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors. ...more
  

BioSenic Relative Risk vs. Return Landscape

If you would invest  0.25  in BioSenic SA on October 12, 2025 and sell it today you would lose (0.03) from holding BioSenic SA or give up 12.0% of portfolio value over 90 days. BioSenic SA is generating negative expected returns and assumes 4.2825% volatility on return distribution over the 90 days horizon. Simply put, 38% of stocks are less volatile than BioSenic, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon BioSenic is expected to under-perform the market. In addition to that, the company is 6.09 times more volatile than its market benchmark. It trades about -0.03 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.17 per unit of volatility.

BioSenic Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for BioSenic's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BioSenic SA, and traders can use it to determine the average amount a BioSenic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.027

High ReturnsBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBIOS

Estimated Market Risk

 4.28
  actual daily
38
62% of assets are more volatile

Expected Return

 -0.12
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.03
  actual daily
0
Most of other assets perform better
Based on monthly moving average BioSenic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioSenic by adding BioSenic to a well-diversified portfolio.

Things to note about BioSenic SA performance evaluation

Checking the ongoing alerts about BioSenic for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioSenic SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BioSenic SA generated a negative expected return over the last 90 days
BioSenic SA has some characteristics of a very speculative penny stock
BioSenic SA has high historical volatility and very poor performance
Evaluating BioSenic's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate BioSenic's stock performance include:
  • Analyzing BioSenic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioSenic's stock is overvalued or undervalued compared to its peers.
  • Examining BioSenic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating BioSenic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioSenic's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of BioSenic's stock. These opinions can provide insight into BioSenic's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating BioSenic's stock performance is not an exact science, and many factors can impact BioSenic's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for BioSenic Stock Analysis

When running BioSenic's price analysis, check to measure BioSenic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioSenic is operating at the current time. Most of BioSenic's value examination focuses on studying past and present price action to predict the probability of BioSenic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioSenic's price. Additionally, you may evaluate how the addition of BioSenic to your portfolios can decrease your overall portfolio volatility.